Sarcopaenia in surgical populations: A review

Rachel S.M. Heard, George Ramsay, Diane R. Hildebrand* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Citations (Scopus)


Sarcopaenia, or decreased muscle mass, has been the subject of a large quantity of recent literature in both medical and surgical disciplines. It has been shown, as outlined below, to be of great prognostic importance, and also may be used in certain circumstances to guide treatment. The greatest volume of research into this topic is in oncological surgical populations, in whom the prevalence of sarcopaenia has been shown to be high. However it is being increasingly studied in other patient groups. Interest in using sarcopaenia as an objective and potentially modifiable marker of frailty is increasing, especially with regards to pre-operative risk stratification and amelioration. In this review we consider the current literature regarding the cause and effect of sarcopaenia, the methods by which it may be identified and the potential ways in which it may be treated, in the interest of improving outcomes for surgical patients.

Original languageEnglish
Pages (from-to)366-371
Number of pages6
Issue number6
Early online date3 Jul 2017
Publication statusPublished - 1 Dec 2017


  • Frailty
  • Sarcopaenia
  • Surgery


Dive into the research topics of 'Sarcopaenia in surgical populations: A review'. Together they form a unique fingerprint.

Cite this